No products in the cart.
Rabbit Polyclonal GAPDH antibody (STJ96417)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IHC, ELISA
Recommended dilution: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000;
Recommended protocols: check protocols
Click or hover above images to see image description for GAPDH Polyclonal Antibody.
Check alternative names for the antibodyExpand
GAPDH antibody, GAPD antibody, CDABP0047 antibody, OK/SW-cl.12 antibody,|Aging associated gene 9 protein antibody|Epididymis secretory sperm binding protein Li 162eP antibody|G3P_HUMAN antibody|G3PD antibody|G3PDH antibody|GAPD antibody|GAPDH antibody|Glyceraldehyde 3 phosphate dehydrogenase antibody|Glyceraldehyde-3-phosphate dehydrogenase antibody|HEL S 162eP antibody|Peptidyl-cysteine S-nitrosylase GAPDH antibody|Anti-GAPDH antibody [mAbcam 9484] – Loading Control (ab9484)
SCBT cat No: sc-47724|sc-59540|sc-32233|sc-51907|sc-69778|sc-81545|sc-66163|sc-20358|sc-137179|sc-166545|sc-25778|sc-365062|sc-166574|sc-48166|sc-48167|sc-31915|sc-20356|sc-20357|
GAPDH Polyclonal Antibody
|Catalogue No.|| |
Human, Mouse, Rat
GAPDH Polyclonal Antibody detects endogenous levels of GAPDH protein.
Synthesized peptide derived from the N-terminal region of human GAPDH
WB, IHC, ELISA
|Recommended dilution|| |
WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000;
|Molecular weight|| |
GAPDH Antibody was tube-contained. Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.04% sodium azide.
GAPDH Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
Glyceraldehyde-3-phosphate dehydrogenase antibody, GAPDH antibody, Peptidyl-cysteine S-nitrosylase GAPDH antibody,
|Protein names|| |
Glyceraldehyde-3-phosphate dehydrogenase , GAPDH , Peptidyl-cysteine S-nitrosylase GAPDH ,
|Protein function|| |
Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC. Modulates the organization and assembly of the cytoskeleton. Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3′-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. / D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH. /
|Protein sequence and domain|| |
The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. / Belongs to the glyceraldehyde-3-phosphate dehydrogenase family.
|Protein post-translational modifications|| |
S-nitrosylation of Cys-152 leads to interaction with SIAH1, followed by translocation to the nucleus (By similarity). S-nitrosylation of Cys-247 is induced by interferon-gamma and LDL(ox) implicating the iNOS-S100A8/9 transnitrosylase complex and seems to prevent interaction with phosphorylated RPL13A and to interfere with GAIT complex activity. / ISGylated. / Sulfhydration at Cys-152 increases catalytic activity. / Oxidative stress can promote the formation of high molecular weight disulfide-linked GAPDH aggregates, through a process called nucleocytoplasmic coagulation. Such aggregates can be observed in vivo in the affected tissues of patients with Alzheimer disease or alcoholic liver cirrhosis, or in cell cultures during necrosis. Oxidation at Met-46 may play a pivotal role in the formation of these insoluble structures. This modification has been detected in vitro following treatment with free radical donor (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide. It has been proposed to destabilize nearby residues, increasing the likelihood of secondary oxidative damages, including oxidation of Tyr-45 and Met-105. This cascade of oxidations may augment GAPDH misfolding, leading to intermolecular disulfide cross-linking and aggregation.
|Protein cellular localization|| |
Cytoplasm > cytosol / Nucleus / Cytoplasm > perinuclear region / Membrane / Cytoplasm > cytoskeleton
AntibodyPlus can customize GAPDH Antibody according to your requirement, including bulk product size,etc. Please contact email@example.com. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: